[1]
|
Rauch, F. and Glorieux, F.H. (2004) Osteogenesis imperfecta. Lancet, 363, 1377-1385.
doi:10.1016/S0140-6736(04)16051-0
|
[2]
|
Plotkin, H. (2004) Syndromes with congenital brittle bones. BMC Pediatrics, 4, 16.
doi:10.1186/1471-2431-4-16
|
[3]
|
Glorieux, F.H. (2008) Osteogenesis imperfecta. Best Practice & Research Clinical Rheumatology, 22, 85-100.
doi:10.1016/j.berh.2007.12.012
|
[4]
|
Van Dijk, F.S., Pals, G., Van Rijn, R.R., Nikkels, P.G. and Cobben, J.M. (2010) Classification of osteogenesis imperfecta revisited. European Journal of Medical Genetics, 53, 1-5. doi:10.1016/j.ejmg.2009.10.007
|
[5]
|
Hackley, L. and Merritt, L. (2008) Osteogenesis imperfecta in the neonate. Advances in Neonatal Care, 8, 21-30. doi:10.1097/01.ANC.0000311013.71510.41
|
[6]
|
Morgan, J.A. and Marcus, P.S. (2010) Prenatal diagnosis and management of intrauterine fracture. Obstetrical & Gynecological Survey, 65, 249-259.
doi:10.1097/OGX.0b013e3181dbc50b
|
[7]
|
Tedeschi, E., Antoniazzi, F., Venturi, G., Zamboni, G. and Tatò, L. (2006) Osteogenesis imperfecta and its molecular diagnosis by determination of mutations of type I collagen genes. Pediatric Endocrinology Reviews, 4, 40-46.
|
[8]
|
Burnei, G., Vlad, C., Georgescu, I. and Gavriliu, T.S. (2008) Osteogenesis imperfecta: Diagnosis and treatment. Journal of the American Academy of Orthopaedic Surgeons, 16, 356-366.
|
[9]
|
Basel, D. and Steiner, R.D. (2009) Osteogenesis imperfecta: Recent findings shed new light on this once well-understood condition. Genetics in Medicine, 11, 375-385. doi:10.1097/GIM.0b013e3181a1ff7b
|
[10]
|
Marini, J.C., Cabral, W.A., Barnes, A.M., Chang and W. (2007) Components of the collagen prolyl 3-hydroxy-lation complex are crucial for normal bone development. Cell Cycle, 6, 1675-1681. doi:10.4161/cc.6.14.4474
|
[11]
|
Tarnowski, M. and Sieroń, A.L. (2008) Osteogenesis imperfecta-etiology, characteristics, current and future treatment. Wiadomosci Lekarskie, 61, 166-172.
|
[12]
|
Dent, C.E. and Davies, I.J. (1980) Calcium metabolism in bone disease: Effects of treatment with microcrystalline calcium hydroxyapatite compound and dihydrotachysterol. Journal of the Royal Society of Medicine, 73, 780-785.
|
[13]
|
Bachrach, L.K. and Ward, L.M. (2009) Clinical review 1: Bisphosphonate use in childhood osteoporosis. The Journal of Clinical Endocrinology & Metabolism, 94, 400-409. doi:10.1210/jc.2008-1531
|
[14]
|
Russell, R.G. (2007) Bisphosphonates: Mode of action and pharmacology. Pediatrics, 119, 150-162.
doi:10.1542/peds.2006-2023H
|
[15]
|
Benhamou, C.L. (2007) Effects of osteoporosis medications on bone quality. Joint Bone Spine, 74, 39-47.
doi:10.1016/j.jbspin.2006.06.004
|
[16]
|
Rauch, F. and Glorieux, F.H. (2005) Bisphosphonate treatment in osteogenesis imperfecta: Which drug, for whom, for how long? Annals of Medicine, 37, 295-302. doi:10.1080/07853890510007386
|
[17]
|
Horwitz, E.M., Prockop, D.J., Fitzpatrick, L.A., et al., (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Medicine, 5, 309-313.
doi:10.1038/6529
|
[18]
|
Horwitz, E.M., Prockop, D.J., Gordon, P.L., et al., (2001) Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood, 97, 1227-1231. doi:10.1182/blood.V97.5.1227
|
[19]
|
Pochampally, R.R., Horwitz, E.M., DiGirolamo, C.M., Stokes, D.S. and Prockop, D.J. (2005) Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: A strategy for rescuing mutations that produce dominant-negative protein defects. Gene Therapy, 12, 1119-1125.
doi:10.1038/sj.gt.3302514
|
[20]
|
Niyibizi, C. and Li, F. (2009) Potential implications of cell therapy for osteogenesis imperfecta. International Journal of Clinical Rheumatology, 4, 57-66.
|
[21]
|
Sillence, D.O., Senn, A. and Danks, D.M. (1979) Genetic heterogeneity in osteogenesis imperfecta. Journal of Medical Genetics, 16, 101-116. doi:10.1136/jmg.16.2.101
|
[22]
|
Witecka, J., Augu?ciak-Duma, A.M., Kruczek, A., et al., (2008) Two novel COL1A1 mutations in patients with osteogenesis imperfecta (OI) affect the stability of the collagen type I triple-helix. Journal of Applied Genetics, 49, 283-295. doi:10.1007/BF03195625
|
[23]
|
Fertala, A., Sieron, A.L., Ganguly, A., et al., (1994) Synthesis of recombinant human procollagen II in a stably transfected tumor cell line (HT-1080). Biochemical Journal, 298, 31-37.
|
[24]
|
Arnold. W.V., Fertala, A., Sieron, A.L., et al., (1998) Recombinant procollagen II: Deletion of D period segments identifies sequences that are required for helix stabilization and generates a temperature-sensitive N-proteinase cleavage site. The Journal of Biological Chemistry, 273, 31822-31828. doi:10.1074/jbc.273.48.31822
|
[25]
|
Stanford, C.M., Jacobson, P.A., Eanes, E.D., Lembke, L.A. and Midura, R.J. (1995) Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). The Journal of Biological Chemistry, 270, 9420-9428.
doi:10.1074/jbc.270.16.9420
|
[26]
|
Gregory, C.A., Gunn, W.G., Peister, A. and Prockop, D.J. (2004) An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Analytical Biochemistry, 329, 77-84. doi:10.1016/j.ab.2004.02.002
|
[27]
|
Marini, J.C., Letocha, A.D. and Chernoff, E.J. (2005) Osteogenesis imperfecta. In: Cassidy, S.B and Allanson, J.E., Eds., Management of genetic syndromes. Published Online: 14 JAN 2005.
http://onlinelibrary.wiley.com/doi/10.1002/0471695998.mgs034/abstract
|
[28]
|
Esposito, P. and Plotkin, H. (2008) Surgical treatment of osteogenesis imperfecta: Current concepts. Current Opinion in Pediatrics, 20, 52-57.
doi:10.1097/MOP.0b013e3282f35f03
|
[29]
|
Marini, J. (2010) Osteogenesis imperfecta. In: Diseases of bone and calcium metabolism. South Dartmouth in US: Mdtext.com.inc.
http://www.endotext.org/parathyroid/parathyroid17/parathyroidframe17.htm
|
[30]
|
Chen, H. (2006) Osteogenesis imperfecta. In: Chen, H., Ed., Atlas of genetic diagnosis and counselling, Humana Press Inc., New Jersey, 762-772.
|